List of Ryzolt drug patents
Ryzolt is owned by Purdue Pharma.
Ryzolt contains Tramadol Hydrochloride.
Ryzolt has a total of 1 drug patent out of which 0 drug patents have expired.
Ryzolt was authorised for market use on 30 December, 2008.
Ryzolt is available in tablet, extended release;oral dosage forms.
The generics of Ryzolt are possible to be released after 27 October, 2023.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7988998 | PURDUE PHARMA | Sustained-release tramadol formulations with 24-hour efficacy |
Oct, 2023
(6 months from now) | |
Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient
Market Authorisation Date: 30 December, 2008
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
RYZOLT family patents
8
United States
5
Canada
3
Brazil
3
Japan
2
Israel
2
South Africa
2
Denmark
2
Austria
2
Mexico
2
Australia
2
Hong Kong
2
Slovenia
2
Russia
2
Norway
2
Germany
2
Argentina
2
Portugal
2
Spain
2
Korea, Republic of
2
Taiwan, Province of China
2
China
2
Ecuador
2
Ukraine
2
New Zealand
2
European Union
1
Malaysia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic